These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 33025174)

  • 41. Changes on chest HRCT in systemic sclerosis-related interstitial lung disease after autologous haematopoietic stem cell transplantation.
    Pugnet G; Petermann A; Collot S; Otal P; Lansiaux P; Ait Abdallah N; Lorillon G; Resche-Rigon M; Borel C; Marjanovic Z; Farge D;
    Rheumatology (Oxford); 2023 Feb; 62(SI):SI32-SI42. PubMed ID: 35686921
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pulmonary hypertension and interstitial lung disease within PHAROS: impact of extent of fibrosis and pulmonary physiology on cardiac haemodynamic parameters.
    Fischer A; Swigris JJ; Bolster MB; Chung L; Csuka ME; Domsic R; Frech T; Hinchcliff M; Hsu V; Hummers LK; Gomberg-Maitland M; Mathai SC; Simms R; Steen VD
    Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-109-14. PubMed ID: 25372796
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predictors of lung function test severity and outcome in systemic sclerosis-associated interstitial lung disease.
    Le Gouellec N; Duhamel A; Perez T; Hachulla AL; Sobanski V; Faivre JB; Morell-Dubois S; Lambert M; Hatron PY; Hachulla E; Béhal H; Matran R; Launay D; Remy-Jardin M
    PLoS One; 2017; 12(8):e0181692. PubMed ID: 28763468
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessment of interstitial lung disease in systemic sclerosis using the quantitative CT algorithm CALIPER.
    Ferrazza AM; Gigante A; Gasperini ML; Ammendola RM; Paone G; Carbone I; Rosato E
    Clin Rheumatol; 2020 May; 39(5):1537-1542. PubMed ID: 31940114
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pericardial abnormalities predict the presence of echocardiographically defined pulmonary arterial hypertension in systemic sclerosis-related interstitial lung disease.
    Fischer A; Misumi S; Curran-Everett D; Meehan RT; Ulrich SK; Swigris JJ; Frankel SK; Cosgrove GP; Lynch DA; Brown KK
    Chest; 2007 Apr; 131(4):988-92. PubMed ID: 17426200
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical Features of Idiopathic Interstitial Pneumonia with Systemic Sclerosis-Related Autoantibody in Comparison with Interstitial Pneumonia with Systemic Sclerosis.
    Yamakawa H; Hagiwara E; Kitamura H; Yamanaka Y; Ikeda S; Sekine A; Baba T; Iso S; Okudela K; Iwasawa T; Takemura T; Kuwano K; Ogura T
    PLoS One; 2016; 11(8):e0161908. PubMed ID: 27564852
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tracking Impact of Interstitial Lung Disease in Systemic Sclerosis in a Complete Nationwide Cohort.
    Hoffmann-Vold AM; Fretheim H; Halse AK; Seip M; Bitter H; Wallenius M; Garen T; Salberg A; Brunborg C; Midtvedt Ø; Lund MB; Aaløkken TM; Molberg Ø
    Am J Respir Crit Care Med; 2019 Nov; 200(10):1258-1266. PubMed ID: 31310156
    [No Abstract]   [Full Text] [Related]  

  • 48. Longitudinal Changes in Quantitative Interstitial Lung Disease on Computed Tomography after Immunosuppression in the Scleroderma Lung Study II.
    Goldin JG; Kim GHJ; Tseng CH; Volkmann E; Furst D; Clements P; Brown M; Roth M; Khanna D; Tashkin DP
    Ann Am Thorac Soc; 2018 Nov; 15(11):1286-1295. PubMed ID: 30265153
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Use of pulmonary function tests and biomarkers studies to diagnose and follow-up interstitial lung disease in systemic sclerosis].
    Hua-Huy T; Rivière S; Tiev KP; Dinh-Xuan AT
    Rev Pneumol Clin; 2014 Dec; 70(6):335-42. PubMed ID: 25457218
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interstitial lung disease in systemic sclerosis: a simple staging system.
    Goh NS; Desai SR; Veeraraghavan S; Hansell DM; Copley SJ; Maher TM; Corte TJ; Sander CR; Ratoff J; Devaraj A; Bozovic G; Denton CP; Black CM; du Bois RM; Wells AU
    Am J Respir Crit Care Med; 2008 Jun; 177(11):1248-54. PubMed ID: 18369202
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Four Corners Sign: A Specific Imaging Feature in Differentiating Systemic Sclerosis-related Interstitial Lung Disease From Idiopathic Pulmonary Fibrosis.
    Walkoff L; White DB; Chung JH; Asante D; Cox CW
    J Thorac Imaging; 2018 May; 33(3):197-203. PubMed ID: 29346191
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quantitative and semi-quantitative computed tomography analysis of interstitial lung disease associated with systemic sclerosis: A longitudinal evaluation of pulmonary parenchyma and vessels.
    Occhipinti M; Bosello S; Sisti LG; Cicchetti G; de Waure C; Pirronti T; Ferraccioli G; Gremese E; Larici AR
    PLoS One; 2019; 14(3):e0213444. PubMed ID: 30861018
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A retrospective cohort study of outcome in systemic sclerosis-associated interstitial lung disease.
    Okamoto M; Fujimoto K; Sadohara J; Furuya K; Kaieda S; Miyamura T; Suematsu E; Kitasato Y; Kawayama T; Ida H; Ichiki M; Hoshino T
    Respir Investig; 2016 Nov; 54(6):445-453. PubMed ID: 27886856
    [TBL] [Abstract][Full Text] [Related]  

  • 54.
    Ledoult E; Morelle M; Soussan M; Mékinian A; Béhal H; Sobanski V; Hachulla E; Huglo D; Le Gouellec N; Remy-Jardin M; Baillet C; Launay D
    Arthritis Res Ther; 2021 Mar; 23(1):76. PubMed ID: 33673861
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection and classification of systemic sclerosis-related interstitial lung disease: a review.
    DeMizio DJ; Bernstein EJ
    Curr Opin Rheumatol; 2019 Nov; 31(6):553-560. PubMed ID: 31415029
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pulmonary Artery Dimensions as a Prognosticator of Transplant-Free Survival in Scleroderma Interstitial Lung Disease.
    Gleason JB; Patel KB; Hernandez F; Hadeh A; Highland KB; Rahaghi F; Mehta JP
    Lung; 2017 Aug; 195(4):403-409. PubMed ID: 28456874
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predicting Mortality in Systemic Sclerosis-Associated Interstitial Lung Disease Using Risk Prediction Models Derived From Idiopathic Pulmonary Fibrosis.
    Ryerson CJ; O'Connor D; Dunne JV; Schooley F; Hague CJ; Murphy D; Leipsic J; Wilcox PG
    Chest; 2015 Nov; 148(5):1268-1275. PubMed ID: 25996795
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Computed tomography-based radiomics decodes prognostic and molecular differences in interstitial lung disease related to systemic sclerosis.
    Schniering J; Maciukiewicz M; Gabrys HS; Brunner M; Blüthgen C; Meier C; Braga-Lagache S; Uldry AC; Heller M; Guckenberger M; Fretheim H; Nakas CT; Hoffmann-Vold AM; Distler O; Frauenfelder T; Tanadini-Lang S; Maurer B
    Eur Respir J; 2022 May; 59(5):. PubMed ID: 34649979
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Computed tomography assessment of evolution of interstitial lung disease in systemic sclerosis: Comparison of two scoring systems.
    Salaffi F; Carotti M; Tardella M; Di Carlo M; Fraticelli P; Fischetti C; Giovagnoni A; Gabrielli A
    Eur J Intern Med; 2020 Jun; 76():71-75. PubMed ID: 32089425
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Ultrasound lung comets: new echographic sign of lung interstitial fibrosis in systemic sclerosis].
    Doveri M; Frassi F; Consensi A; Vesprini E; Gargani L; Tafuri M; Picano E; Della Rossa A; Delle Sedie A; d'Ascanio A; Giacomelli C; Bazzichi L; Bombardieri S
    Reumatismo; 2008; 60(3):180-4. PubMed ID: 18854878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.